Found: 52
Select item for more details and to access through your institution.
2023 Japan Society of clinical oncology clinical practice guidelines update for antiemesis.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 7, p. 873, doi. 10.1007/s10147-024-02535-x
- By:
- Publication type:
- Article
Non-pharmacological treatments for anticipatory nausea and vomiting during chemotherapy: a systematic review and meta-analysis of the Clinical Practice Guidelines for Antiemesis 2023.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 7, p. 889, doi. 10.1007/s10147-024-02536-w
- By:
- Publication type:
- Article
Reply to L. Celio et al.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Switching from FOLFIRI plus cetuximab to FOLFIRI plus bevacizumab based on early tumor shrinkage in RAS wild‐type metastatic colorectal cancer: A phase II trial (HYBRID).
- Published in:
- Cancer Medicine, 2024, v. 13, n. 7, p. 1, doi. 10.1002/cam4.7107
- By:
- Publication type:
- Article
How to select and understand guidelines for patient-reported outcomes: a scoping review of existing guidance.
- Published in:
- BMC Health Services Research, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12913-024-10707-8
- By:
- Publication type:
- Article
Perceptions regarding the concept and definition of patient-reported outcomes among healthcare stakeholders in Japan with relation to quality of life: a cross-sectional study.
- Published in:
- Health & Quality of Life Outcomes, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12955-023-02224-9
- By:
- Publication type:
- Article
Exploratory Biomarker Analysis Using Plasma Angiogenesis-Related Factors and Cell-Free DNA in the TRUSTY Study: A Randomized, Phase II/III Study of Trifluridine/Tipiracil Plus Bevacizumab as Second-Line Treatment for Metastatic Colorectal Cancer.
- Published in:
- Targeted Oncology, 2024, v. 19, n. 1, p. 59, doi. 10.1007/s11523-023-01027-8
- By:
- Publication type:
- Article
Current Status and Issues of the Japan Oncofertility Registry.
- Published in:
- Journal of Adolescent & Young Adult Oncology, 2023, v. 12, n. 4, p. 584, doi. 10.1089/jayao.2022.0110
- By:
- Publication type:
- Article
Trifluridine/tipiracil+bevacizumab (BEV) vs. fluoropyrimidine-irinotecan+BEV as second-line therapy for metastatic colorectal cancer: a randomised noninferiority trial.
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 10, p. 1897, doi. 10.1038/s41416-023-02212-2
- By:
- Publication type:
- Article
Phase I study of envafolimab (KN035), a novel subcutaneous single-domain anti-PD-L1 monoclonal antibody, in Japanese patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 5, p. 1021, doi. 10.1007/s10637-022-01287-7
- By:
- Publication type:
- Article
An exploration of trifluridine/tipiracil in combination with irinotecan in patients with pretreated advanced gastric cancer.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 3, p. 614, doi. 10.1007/s10637-022-01223-9
- By:
- Publication type:
- Article
Genomic Landscape of Primary Tumor Site and Clinical Outcome for Patients with Metastatic Colorectal Cancer Receiving Standard-of-Care Chemotherapy.
- Published in:
- Targeted Oncology, 2022, v. 17, n. 3, p. 343, doi. 10.1007/s11523-022-00880-3
- By:
- Publication type:
- Article
Real-world effectiveness of nivolumab in advanced gastric cancer: the DELIVER trial (JACCRO GC-08).
- Published in:
- Gastric Cancer, 2022, v. 25, n. 1, p. 235, doi. 10.1007/s10120-021-01237-x
- By:
- Publication type:
- Article
Second-line chemotherapy after early disease progression during first-line chemotherapy containing bevacizumab for patients with metastatic colorectal cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Effect of early tumor response on the health-related quality of life among patients on second-line chemotherapy for advanced gastric cancer in the ABSOLUTE trial.
- Published in:
- Gastric Cancer, 2021, v. 24, n. 2, p. 467, doi. 10.1007/s10120-020-01131-y
- By:
- Publication type:
- Article
Correction to: Effect of early tumor response on the health-related quality of life among patients on second-line chemotherapy for advanced gastric cancer in the ABSOLUTE trial.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Molecular detection and clinicopathological characteristics of advanced/recurrent biliary tract carcinomas harboring the FGFR2 rearrangements: a prospective observational study (PRELUDE Study).
- Published in:
- Journal of Gastroenterology, 2021, v. 56, n. 3, p. 250, doi. 10.1007/s00535-020-01735-2
- By:
- Publication type:
- Article
Correction to: Molecular detection and clinicopathological characteristics of advanced/recurrent biliary tract carcinomas harboring the FGFR2 rearrangements: a prospective observational study (PRELUDE Study).
- Published in:
- 2021
- By:
- Publication type:
- corrected article
Second-line chemotherapy using taxane in patients with advanced gastric cancer who presented with severe peritoneal metastasis: a multicenter retrospective study.
- Published in:
- International Journal of Clinical Oncology, 2021, v. 26, n. 2, p. 355, doi. 10.1007/s10147-020-01802-x
- By:
- Publication type:
- Article
A management of neutropenia using granulocyte colony stimulating factor support for chemotherapy consisted of docetaxel, cisplatin and 5-fluorouracil in patients with oesophageal squamous cell carcinoma.
- Published in:
- Japanese Journal of Clinical Oncology, 2021, v. 51, n. 2, p. 199, doi. 10.1093/jjco/hyaa190
- By:
- Publication type:
- Article
Clinical practice guidelines for the management of liver metastases from extrahepatic primary cancers 2021.
- Published in:
- Journal of Hepato -- Biliary -- Pancreatic Sciences, 2021, v. 28, n. 1, p. 1, doi. 10.1002/jhbp.868
- By:
- Publication type:
- Article
Early Tumor Shrinkage and Depth of Response in the Second-Line Treatment for KRAS exon2 Wild-Type Metastatic Colorectal Cancer: An Exploratory Analysis of the Randomized Phase 2 Trial Comparing Panitumumab and Bevacizumab in Combination with FOLFIRI (WJOG6210G)
- Published in:
- Targeted Oncology, 2020, v. 15, n. 5, p. 623, doi. 10.1007/s11523-020-00750-w
- By:
- Publication type:
- Article
Randomized phase II/III study of 5-fluorouracil/l-leucovorin versus 5-fluorouracil/l-leucovorin plus paclitaxel administered to patients with severe peritoneal metastases of gastric cancer (JCOG1108/WJOG7312G).
- Published in:
- Gastric Cancer, 2020, v. 23, n. 4, p. 677, doi. 10.1007/s10120-020-01043-x
- By:
- Publication type:
- Article
Recent Developments of Systemic Chemotherapy for Gastric Cancer.
- Published in:
- Cancers, 2020, v. 12, n. 5, p. 1100, doi. 10.3390/cancers12051100
- By:
- Publication type:
- Article
Phase I study of the anti-heparin-binding epidermal growth factor-like growth factor antibody U3-1565 with cetuximab in patients with cetuximab- or panitumumab-resistant metastatic colorectal cancer.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 2, p. 410, doi. 10.1007/s10637-019-00782-8
- By:
- Publication type:
- Article
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer.
- Published in:
- International Journal of Clinical Oncology, 2020, v. 25, n. 1, p. 1, doi. 10.1007/s10147-019-01485-z
- By:
- Publication type:
- Article
Exploration of potential prognostic biomarkers in aflibercept plus FOLFIRI in Japanese patients with metastatic colorectal cancer.
- Published in:
- Cancer Science, 2019, v. 110, n. 11, p. 3565, doi. 10.1111/cas.14198
- By:
- Publication type:
- Article
Multicenter phase II study of trastuzumab with S-1 plus oxaliplatin for chemotherapy-naïve, HER2-positive advanced gastric cancer.
- Published in:
- Gastric Cancer, 2019, v. 22, n. 6, p. 1238, doi. 10.1007/s10120-019-00973-5
- By:
- Publication type:
- Article
Clinical Implications of Decreased Computed Tomography Value after Ramucirumab in Advanced Gastric Cancer.
- Published in:
- Oncology, 2019, v. 97, n. 2, p. 94, doi. 10.1159/000500326
- By:
- Publication type:
- Article
Fluoropyrimidine with or without platinum as first-line chemotherapy in patients with advanced gastric cancer and severe peritoneal metastasis: a multicenter retrospective study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Targeting EGFR and RAS/RAF Signaling in the Treatment of Metastatic Colorectal Cancer: From Current Treatment Strategies to Future Perspectives.
- Published in:
- Drugs, 2019, v. 79, n. 6, p. 633, doi. 10.1007/s40265-019-01113-0
- By:
- Publication type:
- Article
Phase II trial of aflibercept with FOLFIRI as a second‐line treatment for Japanese patients with metastatic colorectal cancer.
- Published in:
- Cancer Science, 2019, v. 110, n. 3, p. 1032, doi. 10.1111/cas.13943
- By:
- Publication type:
- Article
A subanalysis of Japanese patients in a randomized, double-blind, placebo-controlled, phase 3 trial of nivolumab for patients with advanced gastric or gastro-esophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2)
- Published in:
- Gastric Cancer, 2019, v. 22, n. 2, p. 344, doi. 10.1007/s10120-018-0899-6
- By:
- Publication type:
- Article
Co-operative groups in the development of chemotherapy for gastric cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2019, v. 49, n. 3, p. 210, doi. 10.1093/jjco/hyy176
- By:
- Publication type:
- Article
aCGH Analysis of Predictive Biomarkers for Response to Bevacizumab plus Oxaliplatin‐ or Irinotecan‐Based Chemotherapy in Patients with Metastatic Colorectal Cancer.
- Published in:
- Oncologist, 2019, v. 24, n. 3, p. 327, doi. 10.1634/theoncologist.2018-0119
- By:
- Publication type:
- Article
A Phase 1/1b tolerability study of rilotumumab alone or in combination with cisplatin and capecitabine in Japanese patients with gastric cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2017, v. 47, n. 11, p. 1002, doi. 10.1093/jjco/hyx114
- By:
- Publication type:
- Article
Profile of trifluridine/tipiracil hydrochloride in the treatment of metastatic colorectal cancer: efficacy, safety, and place in therapy.
- Published in:
- OncoTargets & Therapy, 2017, v. 10, p. 4599, doi. 10.2147/OTT.S106101
- By:
- Publication type:
- Article
Phase II study of cetuximab with irinotecan for KRAS wild-type colorectal cancer in Japanese patients.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2017, v. 13, n. 2, p. e132, doi. 10.1111/ajco.12405
- By:
- Publication type:
- Article
Significance of FGF9 gene in resistance to anti-EGFR therapies targeting colorectal cancer: A subset of colorectal cancer patients with FGF9 upregulation may be resistant to anti-EGFR therapies.
- Published in:
- Molecular Carcinogenesis, 2017, v. 56, n. 1, p. 106, doi. 10.1002/mc.22476
- By:
- Publication type:
- Article
Infusion site adverse events in breast cancer patients receiving highly emetic chemotherapy with prophylactic anti-emetic treatment with aprepitant and fosaprepitant: A retrospective comparison.
- Published in:
- Molecular & Clinical Oncology, 2016, v. 4, n. 4, p. 603, doi. 10.3892/mco.2016.769
- By:
- Publication type:
- Article
Phase I/II study of nab-paclitaxel plus gemcitabine for chemotherapy-naive Japanese patients with metastatic pancreatic cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
EGFR and HER2 signals play a salvage role in MEK1-mutated gastric cancer after MEK inhibition.
- Published in:
- International Journal of Oncology, 2015, v. 47, n. 2, p. 499, doi. 10.3892/ijo.2015.3050
- By:
- Publication type:
- Article
Phase II Study of Concurrent Chemoradiotherapy at the Dose of 50.4 Gy with Elective Nodal Irradiation for Stage II–III Esophageal Carcinoma.
- Published in:
- Japanese Journal of Clinical Oncology, 2013, v. 43, n. 6, p. 608, doi. 10.1093/jjco/hyt048
- By:
- Publication type:
- Article
Multicenter Feasibility Study of Combination Therapy with Fluorouracil, Leucovorin and Paclitaxel (FLTAX) for Peritoneal Disseminated Gastric Cancer with Massive Ascites or Inadequate Oral Intake.
- Published in:
- Japanese Journal of Clinical Oncology, 2012, v. 42, n. 9, p. 787, doi. 10.1093/jjco/hys111
- By:
- Publication type:
- Article
Management of adjuvant S-1 therapy after curative resection of gastric cancer: dose reduction and treatment schedule modification.
- Published in:
- Gastric Cancer, 2011, v. 14, n. 1, p. 28, doi. 10.1007/s10120-011-0003-y
- By:
- Publication type:
- Article
Progression-free survival in first-line chemotherapy is a prognostic factor in second-line chemotherapy in patients with advanced gastric cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2010, v. 136, n. 7, p. 1059, doi. 10.1007/s00432-009-0752-8
- By:
- Publication type:
- Article
Adipocytokines as new promising markers of colorectal tumors: Adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer.
- Published in:
- Cancer Science, 2010, v. 101, n. 5, p. 1286, doi. 10.1111/j.1349-7006.2010.01518.x
- By:
- Publication type:
- Article
Palliative radiation therapy for hemorrhage of unresectable gastric cancer: a single institute experience.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2009, v. 135, n. 8, p. 1117, doi. 10.1007/s00432-009-0553-0
- By:
- Publication type:
- Article
Adipocytokine levels in gastric cancer patients: resistin and visfatin as biomarkers of gastric cancer.
- Published in:
- Journal of Gastroenterology, 2009, v. 44, n. 7, p. 685, doi. 10.1007/s00535-009-0063-5
- By:
- Publication type:
- Article
A Phase I Trial of 5-Fluorouracil with Cisplatin and Concurrent Standard-dose Radiotherapy in Japanese Patients with Stage II/III Esophageal Cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2009, v. 39, n. 1, p. 37
- By:
- Publication type:
- Article